Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
about
Intravesical immunotherapy in nonmuscle invasive bladder cancerImmunotherapy for bladder cancer.Gut microbiome and anticancer immune response: really hot Sh*t!Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.Toll-Like Receptor 4 Promotes NO Synthesis by Upregulating GCHI Expression under Oxidative Stress Conditions in Sheep Monocytes/Macrophages1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.Deconvolution of the Response to Bacillus Calmette-Guérin Reveals NF-κB-Induced Cytokines As Autocrine Mediators of Innate Immunity.Future directions in bladder cancer immunotherapy: towards adaptive immunity.Strategies for designing synthetic immune agonists.Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.Pan-urologic cancer genomic subtypes that transcend tissue of origin.TLR2/TLR4 activation induces Tregs and suppresses intestinal inflammation caused by Fusobacterium nucleatum in vivo.
P2860
Q26775979-37BFD299-5043-4F9E-B558-8ECABEA03A32Q34477444-3D199C83-E64D-41AA-ABE2-2E014B2969CAQ34924272-AEDC8EAE-89EC-4EA1-93BA-F72A9E67F594Q35853865-93A1A331-E18C-445D-8B0C-36EB6504C614Q36070462-61C39410-F8B3-4B6E-ACCC-8D9A9FF70F84Q36241519-DAD863F1-6314-4DF7-A49D-5C19D2EC3315Q37589142-E2402398-BB89-4369-9BD8-2CA4998903CAQ38656325-99BB0CB4-3408-4CD5-BA37-3C6616ABE811Q38727522-4D28ECB4-2A86-4097-9BEF-5D9A0B1D0FE4Q38841677-6C91356C-3BA2-49D9-89B8-D11D19B3DA6AQ39457058-582CCF07-E03F-4B72-87FD-82B4D0453FD5Q40071513-582106F9-C266-442E-AF94-DA32D5F6398FQ41243664-FD715F47-EB63-4E4A-928A-3703555719C9Q42708384-A61044EC-CE24-4479-BE08-84F541F67712
P2860
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
@en
type
label
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
@en
prefLabel
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
@en
P2093
P2860
P356
P1476
Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
@en
P2093
Alain Bergeron
Cherifa Ayari
Hélène LaRue
Yves Fradet
P2860
P2888
P304
P356
10.1038/NRUROL.2013.153
P407
P577
2013-08-27T00:00:00Z
P6179
1009573193